Continuous Blood Glucose Monitoring Market Forecast Reaching $23.15 Billion by 2029 at 11.7% CAGR
Discover trends, market shifts, and competitive outlooks for the continuous blood glucose monitoring industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Are the Key Milestones in the Continuous Blood Glucose Monitoring Market’s Growth Trajectory From 2025 To 2034?
The market size of continuous blood glucose monitoring has seen robust growth in the past years. It is set to expand from $13.57 billion in 2024 to $14.87 billion in 2025, with a compound annual growth rate (CAGR) of 9.6%. The surge in growth during the historic period can be credited to the rising prevalence of diabetes, regulatory compliance, the necessity for remote monitoring, burgeoning markets, and increased healthcare spending.
The market size for constant blood glucose monitoring is projected to see fast-paced expansion in the subsequent years, culminating in a value of $23.15 billion in 2029,
backed by a compound annual growth rate (CAGR) of 11.7%. Numerous factors contribute to this growth in the forecast period such as an increasing aging population, expansion within home healthcare and telehealth sectors, a surge in healthcare expenditures, and an increase in disposable income. Wearable integration, the application of artificial intelligence and machine learning, the development of advanced sensors for improved accuracy, and a rise in partnerships and collaborations are key trends expected to shape the forecast period.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13079&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Continuous Blood Glucose Monitoring Market?
The escalating rates of diabetes are projected to boost expansion in the market for continuous blood glucose monitoring. Diabetes is a medical condition that is characterized by unstable blood glucose levels, and continuous blood glucose monitoring devices can assist in identifying patterns and trends, offering a more comprehensive understanding of a patient’s diabetic status. For example, recent reports from the International Diabetes Federation (IDF) indicate that an estimated 537 million adults aged 20 to 79 across the globe are presently living with diabetes. This tally is significantly higher than prior assessments, underscoring an alarming rise in diabetes prevalence. The IDF forecasts an increase to 643 million by 2030, and further to 783 million by 2045. As such, it’s apparent that the growing prevalence of diabetes is a key factor powering the upward trajectory of the continuous blood glucose monitoring market.
Which Key Market Segments Comprise the Continuous Blood Glucose Monitoring Market and Drive Its Revenue Growth?
The continuous blood glucose monitoring market covered in this report is segmented –
1) By Component: Insulin Pumps, Sensors, Transmitters, Receivers
2) By Application: Type 1 Diabetic Patients, Type 2 Diabetic Patients, Gestational Diabetes, Critical Care Patients
3) By End User: Hospitals, Homecare Diagnostics, Other End Users
Subsegments:
1) By Insulin Pumps: Tubeless Insulin Pumps, Tubed Insulin Pumps, Patch Pumps
2) By Sensors: Continuous Glucose Monitoring Sensors, Flash Glucose Monitoring Sensors, Implantable Sensors
3) By Transmitters: Integrated Transmitters, Wireless Transmitters, Bluetooth-enabled Transmitters
4) By Receivers: Standalone Receivers, Smartphone Apps, Integrated Devices
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13079&type=smp
Which Areas Are Leading Regions in the Continuous Blood Glucose Monitoring Market Expansion Across the Globe?
The countries covered in the continous blood glucose monitoring market report include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
What Are the Strategic Trends Steering the Continuous Blood Glucose Monitoring Market Direction?
The surge in technological innovations is becoming a notable trend in the continuous blood glucose monitoring market. Key players in this market are making efforts to create advanced tech solutions to solidify their market standing. For instance, Philips in 2022 extended its portfolio of home care solutions for chronic obstructive pulmonary disease (COPD) patients with the release of BiPAP A40 EFL. This non-invasive ventilator, created to boost patient comfort and cut down on hospital readmissions, utilizes Philips’ unique ExpiraFlow technology. This technology enables healthcare workers to automatically spot expiratory flow limitation (EFL) in COPD patients and deliver customized therapy.
View the full report here:
How Is the Continuous Blood Glucose Monitoring Market Conceptually Defined?
Continuous Blood Glucose Monitoring (CGM) involves using a sensor under the skin to constantly track glucose levels. It provides real-time data and alerts for high or low glucose, assisting people with diabetes in managing their blood sugar levels more effectively.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13079
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
